High-dose flu vaccine linked to 55% lower dementia risk
Updated
Updated · Gavi, the Vaccine Alliance · May 5
High-dose flu vaccine linked to 55% lower dementia risk
10 articles · Updated · Gavi, the Vaccine Alliance · May 5
The April 2026 Neurology finding came from a single retrospective study by the same team whose 2022 research found standard flu vaccination cut Alzheimer’s risk by 40% over four years.
The report says evidence is strongest for shingles, flu, RSV, pneumococcal and DTP vaccines, with large observational studies across multiple countries linking routine adult jabs to 25% to 40% lower dementia risk.
Researchers say vaccines may protect the brain by preventing infection-driven inflammation or through broader immune effects, but they caution the healthy vaccinee effect means the associations do not yet prove causation.
Could your routine flu shot be the key to safeguarding your memory for years to come?
Scientists link vaccines to lower dementia risk, but is a single immune-boosting ingredient the true hero?
Nearly 55% Lower Alzheimer’s Incidence After High-Dose Flu Vaccination: Implications for Aging Populations
Overview
A 2026 study found that adults aged 65 and older who received the high-dose flu vaccine, which contains four times the antigen of the standard dose, experienced a 55% reduction in Alzheimer's disease risk. This protection is linked to the vaccine's ability to prevent flu infections, reducing harmful systemic and brain inflammation, and to modulate the immune system by promoting clearance of amyloid-beta plaques. Women benefit more due to their stronger antibody responses. These findings support CDC recommendations for high-dose flu vaccination as a practical strategy to protect brain health while also preventing severe influenza.